2004論文

1	Leptin kinetics during peritoneal dialysis in acutely uremic rats. Matsubara K, Kiyomoto H, Moriwaki K, Hara T, Kondo N, Shokoji T, Hitomi H, Aki Y, Aono M, Nishiyama A, Ohmori K and Kohno M. Nephrology (Carlton). 9: 256-261, 2004.
2	Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for non-proteolytic activation of prorenin. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AHMN, Ishida Y, Inagami T and Saruta T. J. Clin. Invest. 114: 1128-1135, 2004.
3	Time dependent transition of tempol sensitive reduction of blood pressure in angiotensin II induced hypertension. Kimura S, Zhang G-X, Nagai Y, Miyata K, Nishiyama A, Shokoji T, Yao L, Fan Y-Y, Rahman M, Fujisawa Y, Miyatake A and Abe Y. J. Hypertens. 22: 2161-2168, 2004.
4	Reduction of oxidized low-density lipoprotein by the long-term use of vitamin E-coated dialyzers in hemodialysis patients. Hara T, Takahashi N, Kiyomoto H, Aki Y, Fujioka H, Shokoji T, Matsubara K, Moriwaki K, Kondo N, Kiyomoto K, Hirohata M, Ishizu T, Akiyama K, Nishiyama A, Ohmori K and Kohno M. Dialysis Transplant. 33: 197-202, 2004.
5	Blood flow-dependent changes in intrarenal nitric oxide levels during anesthesia with halothane or sevoflurane. Kusudo K, Ishii K, Rahman M, Aki Y, Miyatake A, Kosaka H, Kimura S, Komatsu T, Yokoyama M, Morita K, Abe Y and Nishiyama A. Eur. J. Pharmacol. 498: 267-273, 2004.
6	Renal effects of a new member of adrenomedullin family, adrenomedullin 2 in rats. Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shokoji T, Nishiyama A, Kimura S and Abe Y. Eur. J. Pharmacol. 497: 75-80, 2004.
7	Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Kohno M, Abe Y and Nishiyama A. Hypertension. 44: 236-243, 2004.
8	Olmesartan improves endotheline-induced hypertension and oxidative stress in rats. Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang G-X, Kimura S, Abe Y and Nishiyama A. Hypertens. Res. 27: 493-500, 2004.
9	Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Majid DSA, Nishiyama A, Jackson KE and Castillo A. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 287: R27-R32, 2004.
10	Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Shokoji T, Kiyomoto H, Kimura S, Kohno M and Abe Y. Hypertension. 43: 841-848, 2004.
11	BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Suzaki Y, Yoshizumi M, Kagami S, Nishiyama A, Ozawa Y, Kyaw M, Izawa Y, Kanematsu Y, Tsuchiya K and Tamaki T. Kidney Int. 65: 1749-1760, 2004
12	Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang G-X, Yao L, Hitomi H, Kiyomoto H, Kimura S, Tamaki T, Kohno M and Abe Y. Kidney Int. 65: 972-981, 2004.
13	Angiotensin II stimulates superoxide production via both angiotensin AT1A and AT1B receptors in mouse aorta and heart. Rahman M, Kimura S, Nishiyama A, Hitomi H, Zhang G-X and Abe Y. Eur. J. Pharmacol. 485: 243-249, 2004.
14	Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Kobori H and Nishiyama A. Biochem. Biophys. Res. Commun. 315: 746-750, 2004.
15	The SOD mimetic tempol ameliorates glomerular injury and reduces MAPK activity in Dahl salt-sensitive rats. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S and Abe Y. J. Am. Soc. Nephrol. 15: 306-315, 2004.
16	ROS during the acute phase of angiotensin II hypertension participates in cardiovascular MAPK activation but not vasoconstriction. Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M and Abe Y. Hypertension. 43: 117-124, 2004.
17	Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Nishiyama A, Rahman M and Inscho EW. Hypertens. Res. 27: 791-804, 2004.
18	Why are angiotensin concentrations so high in the kidney? Navar LG and Nishiyama A. Curr. Opin. Nephrol. Hypertens. 13: 107-115, 2004.
19	Renal renin-angiotensin system. In: Kidney and blood pressure regulation Ichihara A, Kobori H, Nishiyama A and Navar LG. Contrib. Nephrol. 143. Edited by H. Suzuki and T. Saruta. pp. 117-130, 2004. Karger.
20	Mulfunction of Vascular Control in Lifestyle-Related Disease: Oxidative stress of angiotensin II-induced hypertension: Mitogen-activated protein kinases and blood pressure regulation. Kimura S, Zhang GX, Abe Y. Jpn J Pharmacol. (J Pharmacol Sci. に改称)_96: 406-410,2004.
21	Tubuloglomerular feedback (TGF) response in Dahl salt-sensitive hypertensive rats. M Rahman, A Nishiyama, T Yamamoto, T Shokoji, S Kimura, Y Abe. JOURNAL OF PHARMACOLOGICAL SCIENCES 94 265P - 265P 2004.
22	Preventive effect of L-carnosine on ischemic acute renal failure in rats. H Kurata, T Fujii, T Katayama, H Tsutsui, M Takaoka, Y Kiso, Y Fujisawa, T Shokoji, A Nishiyama, Y Abe, Y Matsumura. JOURNAL OF PHARMACOLOGICAL SCIENCES 94 113P - 113P 2004.
23	Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. H Kobori, A Nishiyama. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(3) 746 - 750 2004.